Pharmaceuticals and Healthcare Reports Tourette Syndrome Market Size, Share, Growth, Tren | Page 2

Report Highlights
Pharmaceutical and Healthcare latest pipeline guide Tourette Syndrome - Pipeline Review, H1 2017,
provides comprehensive information on the therapeutics under development for Tourette Syndrome
(Central Nervous System), complete with analysis by stage of development, drug target,
mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the
descriptive pharmacological action of the therapeutics, its complete research and development
history and latest news and press releases.
The Tourette Syndrome (Central Nervous System) pipeline guide also reviews of key players
involved in therapeutic development for Tourette Syndrome and features dormant and discontinued
projects. The guide covers therapeutics under Development by Companies /Universities /Institutes,
the molecules developed by Companies in Phase II, Preclinical and Unknown stages are 7, 1 and 1
respectively. Similarly, the Universities portfolio in Preclinical stages comprises 1 molecules,
respectively.
Request a Sample Copy of This Report @
http://www.radiantinsights.com/research/tourette-syndrome-pipeline-review-h1-
2017/request-sample
Tourette Syndrome (Central Nervous System) pipeline guide helps in identifying and tracking
emerging players in the market and their portfolios, enhances decision making capabilities and
helps to create effective counter strategies to gain competitive advantage. The guide is built using
data and information sourced from Global Markets Direct's proprietary databases,
company/university websites, clinical trial registries, conferences, SEC filings, investor presentations
and featured press releases from company/university sites and industry-specific third party sources.
Additionally, various dynamic tracking processes ensure that the most recent developments are
captured on a real time basis.
Scope




The pipeline guide provides a snapshot of the global therapeutic landscape of Tourette Syndrome
(Central Nervous System).
The pipeline guide reviews pipeline therapeutics for Tourette Syndrome (Central Nervous
System) by companies and universities/research institutes based on information derived from
company and industry-specific sources.
The pipeline guide covers pipeline products based on several stages of development ranging
from pre-registration till discovery and undisclosed stages.
The pipeline guide features descriptive drug profiles for the pipeline products which comprise,
product description, descriptive licensing and collaboration details, R&D brief, MoA & other
developmental activities.

Follow Us: